October 7, 2015
Recommended Topic Related To:

Benztropine Mesylate

"The US Food and Drug Administration (FDA) has approved an extended-release capsule formulation of carbidopa-levodopa (Rytary, IPX066, Impax Pharmaceuticals) for the treatment of Parkinson's disease (PD), postencephalitic parkinsonism, an"...

Benztropine Mesylate

Benztropine Mesylate
Tablets, USP


Benztropine mesylate is a synthetic compound containing structural features found in atropine and diphenhydramine.

It is a crystalline white powder, very soluble in water, designated as 3α-(Diphenylmethoxy)-1αH, 5αH-tropane methanesulfonate, with the following structural formula:

Benztropine mesylate structural formula illustration

Each tablet, for oral administration, contains 0.5 mg, 1 mg or 2 mg of benztropine mesylate.

Each tablet contains the following inactive ingredients: colloidal silicon dioxide, dibasic calcium phosphate lactose monohydrate, microcrystalline cellulose, starch, talc and other ingredients.

Last reviewed on RxList: 6/20/2007
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

WebMD Daily

Get breaking medical news.